同时存在的子宫内膜癌和卵巢癌:分子和病理特征定义了低风险实体
Amy Jamieson1, Jutta Huvila2, Samuel Leung3
1University of British Columbia, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Vancouver, BC, Canada.
概括
FIGO IA3分期系统识别出一个低风险群体的共存子宫内膜和卵巢癌. 纳入分子特征完善了这种分类,可能允许更多患者的治疗降级.
科学领域:
- 妇科瘤学 妇科瘤学
- 病理学 病理学 病理学
- 分子诊断学 分子诊断学
背景情况:
- 同时存在的子宫内膜癌和卵巢癌往往是惰的,并与克隆相关.
- 目前这种实体的病理指标和临床管理高度可变.
- 国际妇科和产科联合会 (FIGO) 2023年系统为特定的共存癌症引入了IA3阶段.
研究的目的:
- 为了验证FIGO阶段IA3是否准确地识别了具有非常低复发风险的共存子宫内膜和卵巢癌.
- 评估分子特征和扩展卵巢病理学标准是否可以提高预后准确性.
- 根据精确的标准,确定适合减缓治疗的患者.
主要方法:
- 临床病理学,分子和结果数据从患有子宫内膜癌和卵巢癌同时存在的患者中收集.
- 数据从病理档案和分子分类的子宫内膜癌队列中提取.
- 分子类型包括p53异常 (p53abn),不匹配修复缺陷 (MMRd),POLE突变 (POLEmut) 和没有特定分子谱 (NSMP) 与雌激素受体 (ER) 状态.
主要成果:
- 在p53abn,MMRd和NSMP ER负的低分子亚型中观察到更高的复发率.
- 32名患者符合FIGO IA3标准,只有一个复发 (MMRd).
- 扩大标准,包括分子特征和更广泛的病理发现,确定了另外48名没有复发的患者,显著改善了风险分层 (p = .008).
- 子宫内膜和卵巢瘤之间的分子亚型一致性很高 (91%).
结论:
- 根据FIGO IA3标准,有效地识别出一组共存的子宫内膜癌和卵巢癌,结果极好.
- 整合分子特征可以提高这些癌症的预后辨别能力.
- 改进的标准支持更大比例的患者 (49%) 缓和治疗,在扩大低风险组中显示零复发.
相关概念视频
Oogenesis
64.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.5K
Ovaries
1.3K
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
On the ovarian surface, a layer of...
1.3K
Disorders of the Female Reproductive System
500
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
500


